Matt Windisch - Kennedy Wilson Ex VP
KW Stock | USD 10.05 0.07 0.70% |
Insider
Matt Windisch is Ex VP of Kennedy Wilson Holdings
Age | 44 |
Address | 151 South El Camino Drive, Beverly Hills, CA, United States, 90212 |
Phone | 310 887 6400 |
Web | https://www.kennedywilson.com |
Kennedy Wilson Management Efficiency
Return On Capital Employed is likely to climb to 0.01 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.04). At this time, Kennedy Wilson's Other Current Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to climb to 37.15 in 2024, whereas Other Assets are likely to drop slightly above 299.3 M in 2024. Kennedy Wilson's management efficiency ratios could be used to measure how well Kennedy Wilson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
W Dukes | Healthpeak Properties | 58 | |
Jamie Barber | Global Medical REIT | 46 | |
Taylor CPA | Omega Healthcare Investors | 62 | |
David Travis | National Health Investors | 49 | |
Tim Staggs | Healthcare Realty Trust | N/A | |
Mary Jensen | Global Medical REIT | N/A | |
Marguerite Nader | Ventas Inc | 52 | |
Gail Makode | Omega Healthcare Investors | 49 | |
Billy Rainey | Healthcare Realty Trust | N/A | |
Eric Gillis | CareTrust REIT | N/A | |
W Adams | National Health Investors | 75 | |
Lori Wittman | Global Medical REIT | 62 | |
Robert CPA | Global Medical REIT | 58 | |
R Horn | Community Healthcare Trust | 53 | |
Julie Wilson | Healthcare Realty Trust | 52 | |
Carey Roberts | Ventas Inc | 49 | |
Lisa EgbuonuDavis | Omega Healthcare Investors | N/A | |
J Hutchens | Ventas Inc | 45 | |
Jingguo Zhang | Global Medical REIT | 55 | |
Maurice Smith | Ventas Inc | 48 | |
Timothy Meyer | Community Healthcare Trust | 47 |
Management Performance
Return On Equity | -0.17 | ||||
Return On Asset | 0.0015 |
Kennedy Wilson Holdings Leadership Team
Elected by the shareholders, the Kennedy Wilson's board of directors comprises two types of representatives: Kennedy Wilson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kennedy. The board's role is to monitor Kennedy Wilson's management team and ensure that shareholders' interests are well served. Kennedy Wilson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kennedy Wilson's outside directors are responsible for providing unbiased perspectives on the board's policies.
In JD, General VP | ||
Mary Ricks, CEO of Kennedy Wilson Europe and President of Kennedy Wilson Europe | ||
Todd Boehly, Independent Director | ||
Emily Heidt, Vice Communications | ||
William McMorrow, Chairman of the Board, Chief Executive Officer | ||
Kent Mouton, Executive Vice President, General Counsel, Director | ||
Richard Boucher, Independent Director | ||
Michael Collins, Chief Europe | ||
Michael Pegler, President Europe | ||
Justin Enbody, CFO and Principal Accounting Officer | ||
Mike Pegler, President Europe | ||
Daven CFA, Vice Relations | ||
Alex Spilger, Head ESG | ||
Norman Creighton, Independent Director | ||
Daven Bhavsar, Vice President of Investor Relations | ||
Regina Finnegan, Executive Resources | ||
Sanaz Zaimi, Independent Director | ||
Kurt Zech, President Group | ||
Parm Nijjar, Managing Europe | ||
Cathy Hendrickson, Independent Director | ||
Matthew Windisch, Executive Vice President | ||
Trevor Bowen, Independent Director | ||
John Taylor, Independent Director | ||
Matt Windisch, Ex VP | ||
Gautam Doshi, Managing Director | ||
David Minella, Lead Independent Director | ||
Stanley Zax, Independent Director | ||
Kent Esq, Senior Director | ||
Fiona DSilva, Head Europe | ||
Katie ONeill, Managing Europe | ||
In Lee, Senior Vice President Deputy General Counsel, Secretary |
Kennedy Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kennedy Wilson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.17 | ||||
Return On Asset | 0.0015 | ||||
Profit Margin | (0.65) % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 7.04 B | ||||
Shares Outstanding | 137.41 M | ||||
Shares Owned By Insiders | 14.09 % | ||||
Shares Owned By Institutions | 90.13 % | ||||
Number Of Shares Shorted | 3.86 M | ||||
Price To Earning | 25.68 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kennedy Stock Analysis
When running Kennedy Wilson's price analysis, check to measure Kennedy Wilson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kennedy Wilson is operating at the current time. Most of Kennedy Wilson's value examination focuses on studying past and present price action to predict the probability of Kennedy Wilson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kennedy Wilson's price. Additionally, you may evaluate how the addition of Kennedy Wilson to your portfolios can decrease your overall portfolio volatility.